Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. antigen receptor
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Business Types

  • Manufacturer
  • Technology
  • Service provider
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals

Antigen Receptor Suppliers & Manufacturers

33 companies found

Cartherics Pty ltd

Cartherics Pty ltd

based inNotting Hill, AUSTRALIA
Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human ...
Cartherics - Off-the-Shelf Involves Induced Pluripotential Stem Cell (iPSC)

Cartherics - Off-the-Shelf Involves Induced Pluripotential Stem Cell (iPSC)

This technology involves induced pluripotential stem cell (iPSC) derived NK cells (and, potentially, other types of immune cells). iPSCs have unlimited capacity for ...
CONTACT SUPPLIER

GeneTex, Inc.

GeneTex, Inc.

based inIrvine, CALIFORNIA (USA)
Established in 1997 by a group of renowned scientists, GeneTex's corporate mission remains clear. While commercial polyclonal and monoclonal antibodies have driven progress in science and medicine since their introduction, the generation of reliable ...
GeneTex - Model CD19 -[HIB19] (PE-Cy7) - Antibody

GeneTex - Model CD19 -[HIB19] (PE-Cy7) - Antibody

The HIB19 antibody reacts with human CD19, a 95 kDa glycoprotein which acts as a co-receptor, along with CD21, CD81 and CD225, in support of the functional B cell receptor (BCR). This complex provides ...
CONTACT SUPPLIER

Vor Biopharma

Vor Biopharma

based inCambridge, MASSACHUSETTS (USA)
We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...
VOR - Model VCAR33 (CD33) - CD33-Directed Chimeric Antigen Receptor T Cell

VOR - Model VCAR33 (CD33) - CD33-Directed Chimeric Antigen Receptor T Cell

Licensed from the National Institutes of Health, VCAR33 is a CD33-directed chimeric antigen receptor T cell (CAR-T) therapy. A T cell therapy using the same CAR construct as VCAR33 is being studied in a multi-site ...
CONTACT SUPPLIER

Celularity Inc.

Celularity Inc.

based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
Celularity - Model CYNK-101 - Genetically-modified PNK Cells

Celularity - Model CYNK-101 - Genetically-modified PNK Cells

We are developing CYNK-101 as a combination treatment for multiple cancer indications. CYNK-101 is manufactured from a specific type of immune cell, NK cells, that we extract from postpartum placentas and then genetically engineer to increase cell ...
CONTACT SUPPLIER

AdAlta Limited

AdAlta Limited

based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta and Carina Biotech - i-body Enabled CAR-T Cancer Therapeutics

AdAlta and Carina Biotech - i-body Enabled CAR-T Cancer Therapeutics

AdAlta and Carina Biotech to develop next-generation i-body enabled CAR-T cancer therapeutics. AdAlta has entered a collaboration agreement with Carina Biotech to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T ...
CONTACT SUPPLIER

Celyad Oncology

Celyad Oncology

based inMont-Saint-Guibert, BELGIUM
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. We are developing a diversified pipeline of allogeneic and autologous CAR T cell ...
Celyad - Model CYAD-02 - Autologous CAR T Candidate

Celyad - Model CYAD-02 - Autologous CAR T Candidate

CYAD-02 is an investigational CAR T therapy that engineers an all-in-one vector approach in patient’s T cells to express both (i) the NKG2D chimeric antigen receptor, a receptor expressed on ...
CONTACT SUPPLIER

CELONIC Group

CELONIC Group

based inBasel, SWITZERLAND
We are a Biologics CDMO (Contract Development and Manufacturing Organization) offering our clients more than just development and manufacturing. In everything we do, we go one step beyond expectations. We enable our customers to exceed their goals ...
CONTACT SUPPLIER

Scancell

Scancell

based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
GlyMab - Model Anti-glycan mAb - Antibodies for Cancer

GlyMab - Model Anti-glycan mAb - Antibodies for Cancer

Glycosylation is a post-translational modification that occurs inside the cell and results in the addition of sugar motifs, “glycans”, to proteins and lipids that are, in most cases, destined for the cell surface. These glycan structures ...
CONTACT SUPPLIER

Celluris

Celluris

based inSão Paulo, BRAZIL
Celluris is the first company in Latin America to develop personalized treatment for cancer patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells into recognizing the tumor as a target, fighting ...
Model CAR-T - Chimeric T Cell Antigen Receptor Therapy

Model CAR-T - Chimeric T Cell Antigen Receptor Therapy

The chimeric T cell antigen receptor therapy, also known as CAR-T, is an immunotherapy that is innovating the treatment of hematological and solid tumors. This new technology is considered less aggressive than ...
CONTACT SUPPLIER

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics Ltd.

based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
PsiOxus - Model T-SIGn - Viral Vector Platform Technology

PsiOxus - Model T-SIGn - Viral Vector Platform Technology

Our clinically validated T-SIGn® viral vector platform delivers multiple transgene payloads that re-program the tumor microenvironment of both primary and metastatic tumors. Our platform can integrate rationally designed synthetic agents to ...
CONTACT SUPPLIER

MtoZ Biolabs

MtoZ Biolabs

based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
MtoZ Biolabs - Oligonucleotide Molecular Weight Analysis Service

MtoZ Biolabs - Oligonucleotide Molecular Weight Analysis Service

Oligonucleotides, composed of 2 to 20 nucleotide units, are increasingly utilized in disease diagnosis and therapeutic applications. They facilitate the introduction of DNA into immune cells, enabling genetic modifications to express chimeric ...
CONTACT SUPPLIER

Chimeric Therapeutics

Chimeric Therapeutics

based inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
Cell Therapy Services

Cell Therapy Services

Cell therapy is the transfer of intact, live cells into a patient to help lessen or cure a disease. The most common and simple type of cell therapy is a blood transfusion. Other commonly known cell therapies include red and white blood cell ...
CONTACT SUPPLIER

ITM Isotope Technologies Munich SE

ITM Isotope Technologies Munich SE

based inGarching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
iQS - Model TS - Theranostics Synthesizer

iQS - Model TS - Theranostics Synthesizer

iQS-TS is a fully automated cassette-based Theranostics Synthesizer facilitating the routine preparation of radiolabeled ...
CONTACT SUPPLIER

Creative Biolabs

Creative Biolabs

based inShirley, NEW YORK (USA)
After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...
CONTACT SUPPLIER

Aptevo Therapeutics

Aptevo Therapeutics

based inSeattle, WASHINGTON (USA)
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative ADAPTIR™ and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for ...
Aptevo - Model APVO603 - Dual Agonist Bispecific Antibody

Aptevo - Model APVO603 - Dual Agonist Bispecific Antibody

APVO603 is a dual agonist bispecific antibody employing a novel mechanism of action to simultaneously target 4-1BB (CD137) and OX40 (CD134), both members of the TNF-receptor family. Dual targeting of 4-1BB and OX40 provides synergistic ...
CONTACT SUPPLIER

Pars Isotope Co

Pars Isotope Co

based inTehran, IRAN
Pars Isotope Co is a prominent supplier and producer of radioisotopes in Iran, catering widely to the medical and industrial sectors. As the sole provider in the region, the company focuses on radiopharmaceuticals used for both the diagnosis and ...
Pars Isotope - Model PARS-LUTOPSMA - Theranostic Radiopharmaceutical for Prostate Cancer

Pars Isotope - Model PARS-LUTOPSMA - Theranostic Radiopharmaceutical for Prostate Cancer

This kit is notable for being the first of its kind globally, and is used in conjunction with the Lu-177 radioisotope. It targets prostate-specific membrane antigen (PSMA), a membrane glycoprotein, the expression of which increases ...
CONTACT SUPPLIER

Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

based inSan Diego, CALIFORNIA (USA)
We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19. Cancer is genetically diverse, highly adaptive, constantly mutating and virtually invisible to ...
Model DAR T - Dimeric Antigen Receptor-T Cell

Model DAR T - Dimeric Antigen Receptor-T Cell

Sorrento utilizes a proprietary knock-out knock-in (KOKI) technology to modify normal healthy donor derived T cells to genetically engineer them to express the dimeric antigen receptor into T-cell ...
CONTACT SUPPLIER

Alphageneron

Alphageneron

based inCambridge, MASSACHUSETTS (USA)
Alphageneron Pharmaceuticals is a clinical-stage biopharmaceutical company developing autologous and allogeneic Natural Killer cells (NK) cell and antibody-based therapies to treat cancer. Our seasoned team of biopharmaceutical executives, ...
Chimeric Antigen Receptor (CAR) NK Cells

Chimeric Antigen Receptor (CAR) NK Cells

Chimeric Antigen Receptor (CAR) NK Cells: Alphageneron is developing ‘off-the- shelf’ umbilical cord (UC) blood- and induced pluripotent stem cell (iPSC)-derived CAR-engineered NK (CAR NK) cell-based ...
CONTACT SUPPLIER

Fate Therapeutics, Inc.

Fate Therapeutics, Inc.

based inSan Diego, CALIFORNIA (USA)
Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. We believe that better cell therapies start with better cells. To ...
Model FT596 - T Cells Engineered with Chimeric Antigen Receptors (CARs)

Model FT596 - T Cells Engineered with Chimeric Antigen Receptors (CARs)

T cells engineered with chimeric antigen receptors (CARs) have shown exceptional promise as a potentially curative therapy for patients with certain hematologic malignancies. While most researchers and clinical ...
CONTACT SUPPLIER

Genscript

Genscript

based inPiscataway, NEW JERSEY (USA)
Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT